A detailed history of Clean Yield Group transactions in Organon & Co. stock. As of the latest transaction made, Clean Yield Group holds 133,420 shares of OGN stock, worth $2.56 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
133,420
Previous 148,598 10.21%
Holding current value
$2.56 Million
Previous $2.79 Million 1.15%
% of portfolio
1.09%
Previous 1.16%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$17.45 - $21.96 $264,856 - $333,308
-15,178 Reduced 10.21%
133,420 $2.76 Million
Q1 2024

May 29, 2024

SELL
$13.78 - $18.8 $520,332 - $709,888
-37,760 Reduced 20.26%
148,598 $2.79 Million
Q4 2023

Jan 24, 2024

SELL
$10.95 - $17.32 $1.1 Million - $1.73 Million
-100,092 Reduced 34.94%
186,358 $2.69 Million
Q3 2023

Oct 12, 2023

BUY
$16.59 - $23.77 $309,619 - $443,619
18,663 Added 6.97%
286,450 $4.97 Million
Q2 2023

Jul 26, 2023

BUY
$19.27 - $24.63 $1.08 Million - $1.38 Million
55,892 Added 26.38%
267,787 $5.57 Million
Q1 2023

Apr 26, 2023

BUY
$21.42 - $32.08 $731,214 - $1.1 Million
34,137 Added 19.2%
211,895 $4.98 Million
Q4 2022

Jan 31, 2023

BUY
$23.31 - $28.61 $2.04 Million - $2.51 Million
87,649 Added 97.27%
177,758 $4.97 Million
Q3 2022

Oct 31, 2022

BUY
$23.4 - $34.25 $2 Million - $2.92 Million
85,377 Added 1804.25%
90,109 $2.11 Million
Q2 2022

Jul 18, 2022

BUY
$31.66 - $38.9 $121,606 - $149,414
3,841 Added 431.09%
4,732 $160,000
Q1 2022

Apr 25, 2022

SELL
$30.45 - $39.36 $3,562 - $4,605
-117 Reduced 11.61%
891 $31,000
Q4 2021

Jan 24, 2022

SELL
$28.67 - $37.13 $3,239 - $4,195
-113 Reduced 10.08%
1,008 $31,000
Q3 2021

Oct 27, 2021

SELL
$28.63 - $35.64 $2,376 - $2,958
-83 Reduced 6.89%
1,121 $37,000
Q2 2021

Jul 26, 2021

BUY
$28.45 - $38.0 $34,253 - $45,752
1,204 New
1,204 $36,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.88B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Clean Yield Group Portfolio

Follow Clean Yield Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.